Department of Chemistry, School of Physical and Chemical Sciences, Queen Mary University of London, London, United Kingdom.
Department of Biomedical Sciences, University of Copenhagen, København N, Denmark.
PLoS Comput Biol. 2023 May 18;19(5):e1011099. doi: 10.1371/journal.pcbi.1011099. eCollection 2023 May.
The druggability of small-molecule binding sites can be significantly affected by protein motions and conformational changes. Ligand binding, protein dynamics and protein function have been shown to be closely interconnected in myosins. The breakthrough discovery of omecamtiv mecarbil (OM) has led to an increased interest in small molecules that can target myosin and modulate its function for therapeutic purposes (myosin modulators). In this work, we use a combination of computational methods, including steered molecular dynamics, umbrella sampling and binding pocket tracking tools, to follow the evolution of the OM binding site during the recovery stroke transition of human β-cardiac myosin. We found that steering two internal coordinates of the motor domain can recapture the main features of the transition and in particular the rearrangements of the binding site, which shows significant changes in size, shape and composition. Possible intermediate conformations were also identified, in remarkable agreement with experimental findings. The differences in the binding site properties observed along the transition can be exploited for the future development of conformation-selective myosin modulators.
小分子结合位点的成药性可能会受到蛋白质运动和构象变化的显著影响。肌球蛋白中的配体结合、蛋白质动力学和蛋白质功能已被证明是紧密相互关联的。奥马环素(OM)的突破性发现导致人们对能够靶向肌球蛋白并调节其功能以达到治疗目的的小分子(肌球蛋白调节剂)产生了浓厚的兴趣。在这项工作中,我们使用了包括导向分子动力学、伞形采样和结合口袋跟踪工具在内的多种计算方法,来跟踪 OM 结合位点在人β-心脏肌球蛋白恢复冲程转变过程中的演变。我们发现,引导两个马达域的内部坐标可以重新捕获过渡的主要特征,特别是结合位点的重排,这表明其在大小、形状和组成上都发生了显著变化。还确定了可能的中间构象,与实验结果非常吻合。在整个过渡过程中观察到的结合位点性质的差异可用于未来开发构象选择性肌球蛋白调节剂。